Panel discussion/ Q&A: Regulation, consumer acceptance, and risk management

dc.contributor.author	Hoban, Thomas
dc.contributor.author	Nolan, Canice
dc.contributor.author	Bennett, Allan
dc.date.accessioned	2017-06-07T17:49:27Z
dc.date.available	2017-06-07T17:49:27Z
dc.date.issued	2005
dc.description.abstract	Panelists expressed highly critical opinions of industry, government and universities regarding agricultural biotechnology and its products, especially those from cloned animals and PMPs from food crops, identified the major problem in European acceptance of GM foods as the consumer not the regulators; food processors aren’t going to source when risk is commonly associated with GM, and described the Public Intellectual Property Resource for Agriculture (PIPRA) that hopes to provide bundles of proprietary technologies to allow the benefits of biotechnology to accrue to a broader base of crops and consumers and developing-country farmers.
dc.identifier.uri	https://hdl.handle.net/1813/51014
dc.language.iso	en_US
dc.publisher	NABC
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International	*
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.subject	Agricultural biotechnology
dc.subject	environment, human health
dc.subject	GMO, genetic engineering, pharming
dc.subject	plant based vaccines
dc.subject	medicinals
dc.subject	regulation
dc.subject	liability, patents
dc.subject	stewardship
dc.title	Panel discussion/ Q&A: Regulation, consumer acceptance, and risk management
dc.type	book chapter

Files

Now showing 1 - 1 of 1